G. Devi, C. Van Berckelaer, S. Van Laere, J. Geradts, S. Lee, M. Morse, L. Dirix, M. Kockx, F. Bertucci, P. van Dam
{"title":"XIAP 过度表达的炎症性乳腺癌患者具有较高的免疫抑制亚群浸润性,TNFR1 信号增加,泛 IAP 拮抗剂 Birinapant 可作为靶向药物。","authors":"G. Devi, C. Van Berckelaer, S. Van Laere, J. Geradts, S. Lee, M. Morse, L. Dirix, M. Kockx, F. Bertucci, P. van Dam","doi":"10.1016/j.ejca.2024.113819","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":505596,"journal":{"name":"European Journal of Cancer","volume":"8 21","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"XIAP overexpressing Inflammatory Breast Cancer Patients have high Infiltration of immunosuppressive subsets and increased TNFR1 signaling targetable with Birinapant, a pan- IAP antagonist\",\"authors\":\"G. Devi, C. Van Berckelaer, S. Van Laere, J. Geradts, S. Lee, M. Morse, L. Dirix, M. Kockx, F. Bertucci, P. van Dam\",\"doi\":\"10.1016/j.ejca.2024.113819\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":505596,\"journal\":{\"name\":\"European Journal of Cancer\",\"volume\":\"8 21\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ejca.2024.113819\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.ejca.2024.113819","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
XIAP overexpressing Inflammatory Breast Cancer Patients have high Infiltration of immunosuppressive subsets and increased TNFR1 signaling targetable with Birinapant, a pan- IAP antagonist